Effectiveness of a Visual Telerehabilitation Program on Visual Perception in Children, Adolescents and Young Adults With Hemianopsia Consecutive to a Brain Tumour
REVIIH-BT
2 other identifiers
interventional
120
7 countries
8
Brief Summary
Evaluate the efficiency of audiovisual stimulation in virtual reality for improving the visual perception of children, adolescents, and young adults with hemianopia resulting from pediatric brain tumors. These individuals can lose up to 50% of their visual field, significantly impacting their independence, mobility, and daily lives.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Longer than P75 for not_applicable
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 25, 2025
CompletedFirst Posted
Study publicly available on registry
April 30, 2026
CompletedStudy Start
First participant enrolled
May 15, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2029
Study Completion
Last participant's last visit for all outcomes
September 1, 2029
April 30, 2026
April 1, 2026
3.3 years
November 25, 2025
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Visual field perimetry measured using the Esterman binocular field test
Increase at least 3 points in the number of points perceived in the blind field at the Esterman binocular field test after intervention (8 weeks) when compared to baseline and between control and interventional group.
From enrollment to the end of follow up period at 6 months
Secondary Outcomes (2)
Participant-reported a vision impairment specific quality of life questionnaire: Impact of Vision Impairment Questionnaire (IVI).
From enrollment to the end of follow up period at 6 months
Reading speed - Minnesota Low Vision Reading (MNREAD) test
From enrollment to the end of follow up period at 6 months
Study Arms (2)
Control
OTHERStandard of care for the first 8 weeks then visual stimulation for the following 8 weeks
Intervention
OTHERVisual stimulation for the first 8 weeks then standard of care for the following 8 weeks
Interventions
Our audiovisual stimulation procedure IVR, called 3D-MOT, was encoded using the the 3D Unity programming platform and deployed in HMDs with built-in head/eye tracking. We implemented the multiple object tracking (MOT) paradigm, developed in the 80's to study visual attention in humans, and added correlated spatial sound.
During this phase, the patients will be at home without a headset and will not be exposed to an audio-visual stimulation task in virtual reality.
Eligibility Criteria
You may qualify if:
- Male and Female
- years old
- Diagnosed hemianopsia (\>12 months)
- History of diagnosis brain tumour
- Being stable for the tumour for \> 6 months (either on therapy or not)
- Visual acuity ≤ 0.7 LogMAR
- Ability to follow the visual and auditory stimuli and training instructions
- Home WiFi access
- Ability to attend all on site visits
- Affiliation to the Social Security or beneficiary of such social protection
You may not qualify if:
- Age\< 10 years old of \> 40 years old
- Ocular disease
- Inability to perform during testing or training
- History of vertigo
- Prior vision rehabilitation interventions
- Recreational or medicinal consumption of psychoactive drugs
- Persons under court protection
- Interpupillary distance \< 54mm
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (8)
Department of Paediatric and adolescents medicine, Medical University
Vienna, Austria
Paediatrics and Adolescents Medicine, University Hospital
Copenhagen, Denmark
Hôpital de Hautepierre
Strasbourg, France
Institute of Tumour, department of haematology and Oncohaematology paediatric
Milan, Italy
Paediatric Haematology, University Hospital
Padova, Italy
Princess Maxima Centre for Paediatric Oncology
Utrecht, Netherlands
Paediatric Oncology, San Joan de Deu
Barcelona, Spain
Great Ormond Street Hospital for Children
London, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2025
First Posted
April 30, 2026
Study Start (Estimated)
May 15, 2026
Primary Completion (Estimated)
September 1, 2029
Study Completion (Estimated)
September 1, 2029
Last Updated
April 30, 2026
Record last verified: 2026-04